Our results provide novel evidence that the aberrant decreases in Ik-1 and MZF1 contribute significantly to the pathogenesis of NPM-ALK+ T-cell lymphoma through the upregulation of IGF-IR expression. The gene discussed is IGF1R; the disease is T-cell non-Hodgkin lymphoma.